Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis-Reference-Cited by-同舟云学术

Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis

Published:2019-05-20 Issue:8 Volume:26 Page:951-960
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Back David¹,Belperio Pamela²^ORCID,Bondin Mark³,Negro Francesco⁴,Talal Andrew H.⁵^ORCID,Park Caroline³,Zhang ZhenZhen³,Pinsky Brett³,Crown Eric³,Mensa Federico J.³,Marra Fiona¹

Affiliation:

1. University of Liverpool Liverpool UK

2. U.S. Department of Veterans Affairs VA Palo Alto Healthcare System Palo Alto California

3. AbbVie Inc North Chicago Illinois

4. University of Geneva Geneva Switzerland

5. Jacobs School of Medicine and Biomedical Sciences University of Buffalo Buffalo New York

Funder

AbbVie

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13110

Reference50 articles.

1. Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview

2. Psychiatric care of the patient with hepatitis C: a review of the literature;Rifai MA;Primary Care Companion to The Journal of Clinical Psychiatry,2010

3. Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications

4. Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimens

5. Patient‐reported outcomes with direct‐acting antivirals for the treatment of chronic hepatitis C: current knowledge and outstanding issues;Marcellin F;Expert Rev Gastroenterol Hepatol,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study;BMC Infectious Diseases;2024-02-23

2. Direct‑acting antiviral treatment is safe and effective for chronic HCV patients with psychiatric disorders;Experimental and Therapeutic Medicine;2023-07-07

3. Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders;World Journal of Gastroenterology;2023-07-07

4. Characteristics associated with receipt of treatment among patients diagnosed with chronic hepatitis C virus;Journal of Viral Hepatitis;2023-06-28

5. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review;Gastroenterología y Hepatología;2023-05